Christopher J. Dinsmore,C. Blair Zartman,Jeffrey M. Bergman,Marc Abrams,Carolyn A. Buser,Joseph Culberson,Joseph P. Davide,Michelle Ellis-Hutchings,Christine Fernandes,Samuel Graham,George D. Hartman,Hans E. Huber,Robert B. Lobell,Scott D. Mosser,R. Robinson,Theresa M. Williams
A series of macrocyclic piperazinone compounds with dual farnesyltransferase/geranylgeranyltransferase-I inhibitory activity was prepared. These compounds were found to be potent inhibitors of protein prenylation in cell culture. A hypothesis for the binding mode of compound 3o in FPTase is proposed.